|
1
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al: European Organisation for Research and Treatment of
Cancer Brain Tumor and Radiotherapy Groups; National Cancer
Institute of Canada Clinical Trials Group: Radiotherapy plus
concomitant and adjuvant temozolomide for glioblastoma. N Engl J
Med. 352:987–996. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cuddapah VA, Robel S, Watkins S and
Sontheimer H: A neurocentric perspective on glioma invasion. Nat
Rev Neurosci. 15:455–465. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang JA, Li JQ, Shao LM, Yang Q, Liu BH,
Wu TF, Wu P, Yi W and Chen QX: Puerarin inhibits proliferation and
induces apoptosis in human glioblastoma cell lines. Int J Clin Exp
Med. 8:10132–10142. 2015.PubMed/NCBI
|
|
4
|
Lee DH, Kim DW, Jung CH, Lee YJ and Park
D: Gingerol sensitizes TRAIL-induced apoptotic cell death of
glioblastoma cells. Toxicol Appl Pharmacol. 279:253–265. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Son YG, Kim EH, Kim JY, Kim SU, Kwon TK,
Yoon AR, Yun CO and Choi KS: Silibinin sensitizes human glioma
cells to TRAIL-mediated apoptosis via DR5 up-regulation and
down-regulation of c-FLIP and survivin. Cancer Res. 67:8274–8284.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vattem DA and Shetty K: Biological
function of ellagic acid: A Review. J Food Biochem. 29:234–266.
2005. View Article : Google Scholar
|
|
7
|
Zaveri NT: Green tea and its polyphenolic
catechins: Medicinal uses in cancer and noncancer applications.
Life Sci. 78:2073–2080. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Seeram NP, Adams LS, Henning SM, Niu Y,
Zhang Y, Nair MG and Heber D: In vitro antiproliferative, apoptotic
and antioxidant activities of punicalagin, ellagic acid and a total
pomegranate tannin extract are enhanced in combination with other
polyphenols as found in pomegranate juice. J Nutr Biochem.
16:360–367. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Han DH, Lee MJ and Kim JH: Antioxidant and
apoptosis-inducing activities of ellagic acid. Anticancer Res 26
(5A). 3601–3606. 2006.
|
|
10
|
Strati A, Papoutsi Z, Lianidou E and
Moutsatsou P: Effect of ellagic acid on the expression of human
telomerase reverse transcriptase (hTERT) α+β+ transcript in
estrogen receptor-positive MCF-7 breast cancer cells. Clin Biochem.
42:1358–1362. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Saiko P, Steinmann MT, Schuster H, Graser
G, Bressler S, Giessrigl B, Lackner A, Grusch M, Krupitza G,
Bago-Horvath Z, et al: Epigallocatechin gallate, ellagic acid, and
rosmarinic acid perturb dNTP pools and inhibit de novo DNA
synthesis and proliferation of human HL-60 promyelocytic leukemia
cells: Synergism with arabinofuranosylcytosine. Phytomedicine.
22:213–222. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Arulmozhi V, Pandian K and Mirunalini S:
Ellagic acid encapsulated chitosan nanoparticles for drug delivery
system in human oral cancer cell line (KB). Colloids Surf B
Biointerfaces. 110:313–320. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao M, Tang SN, Marsh JL, Shankar S and
Srivastava RK: Ellagic acid inhibits human pancreatic cancer growth
in Balb c nude mice. Cancer Lett. 337:210–217. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Okla M, Kang I, Kim DM, Gourineni V, Shay
N, Gu L and Chung S: Ellagic acid modulates lipid accumulation in
primary human adipocytes and human hepatoma Huh7 cells via discrete
mechanisms. J Nutr Biochem. 26:82–90. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Umesalma S and Sudhandiran G: Ellagic acid
prevents rat colon carcinogenesis induced by 1, 2 dimethyl
hydrazine through inhibition of AKT-phosphoinositide-3 kinase
pathway. Eur J Pharmacol. 660:249–258. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo W, Li A, Jia Z, Yuan Y, Dai H and Li
H: Transferrin modified PEG-PLA-resveratrol conjugates: In vitro
and in vivo studies for glioma. Eur J Pharmacol. 718:41–47. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Purow B: Notch inhibition as a promising
new approach to cancer therapy. Adv Exp Med Biol. 727:305–319.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Koch U and Radtke F: Notch and cancer: A
double-edged sword. Cell Mol Life Sci. 64:2746–2762. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cory S, Huang DC and Adams JM: The Bcl-2
family: Roles in cell survival and oncogenesis. Oncogene.
22:8590–8607. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Steeg PS: Tumor metastasis: Mechanistic
insights and clinical challenges. Nat Med. 12:895–904. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pavelic S Kraljevic, Sedic M, Bosnjak H,
Spaventi S and Pavelic K: Metastasis: New perspectives on an old
problem. Mol Cancer. 10:222011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
McCarthy N: Metastasis: Route master. Nat
Rev Cancer. 9:610–611. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
23
|
McCarthy N: Metastasis: Influencing bad
behaviour. Nat Rev Cancer. 9:6092009. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nguyen DX, Bos PD and Massagué J:
Metastasis: From dissemination to organ-specific colonization. Nat
Rev Cancer. 9:274–284. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
25
|
Grossman SA and Batara JF: Current
management of glioblastoma multiforme. Semin Oncol. 31:635–644.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Landete JM: Ellagitannins, ellagic acid
and their derived metabolites: A review about source, metabolism,
functions and health. Food Res Int. 44:1150–1160. 2011. View Article : Google Scholar
|
|
27
|
Hernández L, Terradas M, Martín M, Tusell
L and Genescà A: Highly sensitive automated method for DNA damage
assessment: gamma-H2AX foci counting and cell cycle sorting. Int J
Mol Sci. 14:15810–15826. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koseoglu S, Lu Z, Kumar C, Kirschmeier P
and Zou J: AKT1, AKT2 and AKT3-dependent cell survival is cell
line-specific and knockdown of all three isoforms selectively
induces apoptosis in 20 human tumor cell lines. Cancer Biol Ther.
6:755–762. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang D, Chen Q, Liu B, Li Y, Tan Y and
Yang B: Ellagic acid inhibits proliferation and induces apoptosis
in human glioblastoma cells. Acta Cir Bras. 31:143–149. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Palena C, Hamilton DH and Fernando RI:
Influence of IL-8 on the epithelial-mesenchymal transition and the
tumor microenvironment. Future Oncol. 8:713–722. 2012. View Article : Google Scholar : PubMed/NCBI
|
